Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.
Stock data | 2024 | Change |
---|---|---|
Price | $0.0001 | N/A |
Market Cap | $2.70K | N/A |
Shares Outstanding | 27.02M | N/A |
Employees | 4.00 | N/A |